#	Pagina
attuale pagina	/open-h2020/projects/215894/index.html
-1	/open-h2020/projects/193428/index.html

Opendata, web and dolomites

OSTEOproSPINE SIGNED

Novel Bone Regeneration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

OSTEOproSPINE project word cloud

Explore the words cloud of the OSTEOproSPINE project. It provides you a very rough idea of what is the project "OSTEOproSPINE" about.

safety osteotomy autologous therapy presumptive randomized severity vienna posterolateral blinded suffering excellent distal conduct humans assembled surgery approval iliac intractable recombinant molecular quality evaluation replace disorders degenerative coagulum care spinal weight microenvironment 180 restore protein efficacy administration designed tibial fracture allograft centers disease functioning trial pain harvested function osteoprospine cells resistant guide rhbmp6 treatment committee reinforced grant clinical rate permissive positive osteogrow patient ground autograft radius evaluator spine life disc bearing back bone extra population skeletal trials site supporting patients delivered signals outcome exhibited matrix correct granted 13 health human fp7 blood enroll morphogenetic reduce standard medicine crest vertebrae chronic conditional generating peripheral 279239 form confirm regenerative ethics profile compression fusion regeneration lumbar

Project "OSTEOproSPINE" data sheet

The following table provides information about the project.

Coordinator	SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET Organization address address: SALATA 3 city: ZAGREB postcode: 10 000 website: www.mef.unizg.hr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Croatia [HR]
Total cost	6˙004˙152 €
EC max contribution	6˙004˙152 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SC1-2017-Single-Stage-RTD
Funding Scheme	RIA
Starting year	2018
Duration (year-month-day)	from 2018-01-01 to 2022-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET Organization address address: SALATA 3 city: ZAGREB postcode: 10 000 website: www.mef.unizg.hr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (ZAGREB)	coordinator	710˙750.00
2	GENERA ISTRAZIVANJA DRUSTVO S OGRANICENOM ODGOVORNOSCU ZA PROIZVODNJU BIOTEHNOLOSKIH PROIZVODA GENERA ISTRAZIVANJA DRUSTVO S OGRANICENOM ODGOVORNOSCU ZA PROIZVODNJU BIOTEHNOLOSKIH PROIZVODA Organization address address: SVETONEDJELJSKA 2 city: KALINOVICA postcode: 10436 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (KALINOVICA)	participant	1˙138˙750.00
3	MEDIZINISCHE UNIVERSITAET WIEN MEDIZINISCHE UNIVERSITAET WIEN Organization address address: SPITALGASSE 23 city: WIEN postcode: 1090 website: www.meduniwien.ac.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (WIEN)	participant	848˙625.00
4	CLINRES FARMACIJA RAZISKAVE DOO CLINRES FARMACIJA RAZISKAVE DOO Organization address address: VILHARJEVA CESTA 29 city: LJUBLJANA postcode: 1000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SI (LJUBLJANA)	participant	705˙762.00
5	EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH Organization address address: HEINRICH-HERTZ-ALLEE 1 city: ST INGBERT postcode: 66386 website: www.eurice.eu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (ST INGBERT)	participant	454˙375.00
6	UNIVERSITAT LINZ UNIVERSITAT LINZ Organization address address: ALTENBERGER STRASSE 69 city: LINZ postcode: 4040 website: www.jku.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (LINZ)	participant	423˙750.00
7	2KMM SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 2KMM SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA Organization address address: UL AL W KORFANTENGO 79 city: KATOWICE postcode: 40 161 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PL (KATOWICE)	participant	377˙250.00
8	MEDIZINISCHE UNIVERSITAT GRAZ MEDIZINISCHE UNIVERSITAT GRAZ Organization address address: AUENBRUGGERPLATZ 2 city: GRAZ postcode: 8036 website: http://www.medunigraz.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (GRAZ)	participant	347˙500.00
9	QBEX GMBH QBEX GMBH Organization address address: ST. VEITER RING 1A city: KLAGENFURT postcode: 9020 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (KLAGENFURT)	participant	295˙346.00
10	SMART-MEDICO DOO SMART-MEDICO DOO Organization address address: ZUPANOVA 5 city: ZAGREB postcode: 10000 website: www.smart-medico.hr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (ZAGREB)	participant	253˙532.00
11	UNIVERSITY OF ZAGREB-FACULTY OF VETERINARY MEDICINE UNIVERSITY OF ZAGREB-FACULTY OF VETERINARY MEDICINE Organization address address: HEINZELOVA 55 city: ZAGREB postcode: 10000 website: www.vef.hr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (ZAGREB)	participant	251˙250.00
12	TRIADELTA PARTNERI DOO ZA ISTRAZIVANJE I RAZVOJ TRIADELTA PARTNERI DOO ZA ISTRAZIVANJE I RAZVOJ Organization address address: MEDIMURSKA 19/2 city: ZAGREB GRAD ZAGREB postcode: 10000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (ZAGREB GRAD ZAGREB)	participant	183˙107.00
13	PAUL REGULATORY SERVICES LIMITED PAUL REGULATORY SERVICES LIMITED Organization address address: FISHER HILL WAY 15 city: CARDIFF postcode: CF15 8DR website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (CARDIFF)	participant	14˙154.00
14	OPCA BOLNICA VARAZDIN OPCA BOLNICA VARAZDIN Organization address address: IVANA MESTROVICA 1 city: VARAZDIN postcode: 42000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (VARAZDIN)	participant	0.00

Map

Project objective

We propose a clinical program for the evaluation of a novel bone-regeneration product OSTEOproSPINE as a treatment for intractable chronic back pain. OSTEOproSPINE is a novel bone regeneration therapy composed of OSTEOGROW (recombinant human bone morphogenetic protein 6 [rhBMP6] delivered in autologous peripheral blood coagulum) reinforced with allograft (a compression resistant matrix). OSTEOproSPINE is designed to guide the formation of new bone at extra-skeletal site and replace autograft harvested from patient’s iliac crest for the fusion of lumbar vertebrae. By generating new bone, OSTEOproSPINE will restore the spine’s weight bearing function, reduce the severity of back pain and improve the success rate of posterolateral spinal fusion surgery. The program consortium of 13 partners from 6 EU member states has been assembled to conduct a Phase II, randomized, patient- and evaluator-blinded clinical trial of OSTEOproSPINE. Four clinical centers will enroll 180 patients suffering from degenerative disc disease to assess OSTEOproSPINE efficacy and safety in comparison with Standard of care (autograft) and Osteogrow. The Ethics Committee of the leading clinical site in Vienna has already granted a conditional approval for this trial. As the coordinating institution of the FP7 HEALTH project Osteogrow (Grant No. 279239), we have evaluated Osteogrow in Phase I/II clinical trials for distal radius fracture and high tibial osteotomy. Osteogrow exhibited excellent safety profile in these trials, supporting OSTEOproSPINE safety for administration in humans. A positive outcome of proposed trial will confirm OSTEOproSPINE potential to form a functioning new bone in human and by this restore the spine’s function and improve the quality of life in patients with degenerative disc disorders using the ground principle of regenerative medicine: “provide the correct molecular signals to a population of presumptive cells in a permissive microenvironment”.

Deliverables

List of deliverables.
Data Management Plan	Open Research Data Pilot	2019-10-03 18:11:11
Public project website	Websites, patent fillings, videos etc.	2019-10-03 18:11:11

Take a look to the deliverables list in detail: detailed list of OSTEOproSPINE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OSTEOPROSPINE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OSTEOPROSPINE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More